comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-30 05:03:39 - browse：81

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： In science, is the line between industry and academia shifting?

WSS

What do new weight loss drugs mean for bariatric surgery?

AstraZeneca bets AAV gene therapy will still deliver the goods

Donald Trump's relentless attacks on special counsel Jack Smith

In areas with more Black doctors, Black people live longer

Neuroscience startup Neumora files for IPO

Drug firms test therapies to halt Alzheimer’s before symptoms arise

knowledge

comprehensive

hotspot

New air purifier tech could be key to improving indoor air quality

CDC concerned about possible undetected monkeypox spread in U.K.

ChatGPT in medicine: STAT answers readers' burning questions

Psilocybin's anti

State Dept. review finds Biden bears some blame for Afghanistan failures

CDC concerned about possible undetected monkeypox spread in U.K.

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Departing Stanford president retracts two papers

Hollywood unions extend contract negotiations for actors

Donald Trump's relentless attacks on special counsel Jack Smith

knowledge

How a symptom of dementia informs our understanding of creativity

As pharma fights Medicare drug negotiation, hospitals, docs silent

The battle over the Brookhaven Landfill on Long Island

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

2024 GOP presidential candidates spar over abortion in debate

CDC concerned about possible undetected monkeypox spread in U.K.

explore

hotspot

entertainment

knowledge